Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT01917981 Withdrawn - Stroke Clinical Trials

Testing the Accuracy of a Personal Heart Rhythm Monitor to Detect Prolonged Paroxysmal Atrial Fibrillation

Start date: September 2013
Phase: Phase 3
Study type: Interventional

This study aims to determine the sensitivity and specificity of a Personal Heart Rhythm Monitor in the detection of prolonged paroxysmal atrial fibrillation (defined as lasting more than 12 hours) against pre-existing implantable devices, seen to be the 'gold-standard' for arrhythmia detection.

NCT ID: NCT01917955 Completed - Stroke Clinical Trials

Cardiac MRI in Ischemic Stroke Study

CaMriSS
Start date: January 2012
Phase: N/A
Study type: Observational

The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.

NCT ID: NCT01916486 Completed - Stroke Clinical Trials

Vitality: Promoting Cognitive Function in Older Adults With Chronic Stroke

Vitality
Start date: November 2013
Phase: N/A
Study type: Interventional

The investigators will conduct a randomized controlled trial study to provide preliminary evidence of efficacy of exercise training or a complex mental and social activities program for improving cognitive function in older adults with chronic stroke, compared with a stretch and relaxation program.

NCT ID: NCT01915862 Completed - Ischemic Stroke Clinical Trials

Blood Pressure Variability in Acute Ischemic Stroke

PREVISE
Start date: August 2013
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is the evaluation and comparison of blood pressure variability indices and ambulatory arterial stiffness index obtained by ambulatory blood pressure monitoring as prognostic indicators in the functional outcome of acute ischemic stroke.

NCT ID: NCT01915459 Completed - Stroke Clinical Trials

Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity

Start date: June 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Botulax® compared to Botox® reducing upper limb muscle tone in post stroke patients.

NCT ID: NCT01915368 Completed - Stroke Clinical Trials

Determining Optimal Post-Stroke Exercise (DOSE)

Start date: September 2013
Phase: N/A
Study type: Interventional

The investigators will conduct a proof-of-concept study to provide preliminary evidence of efficacy of physical exercise dose on ambulatory function in adults undergoing sub-acute stroke rehabilitation.

NCT ID: NCT01913509 Completed - Stroke Clinical Trials

A Study of Post-Stroke Pain and Fatigue: Clinical Evaluation and Treatment Effect

Start date: December 2013
Phase: N/A
Study type: Interventional

The investigators anticipate this research will shed light on metric properties of outcome measures of pain and fatigue and the effects of the combined therapy for stroke patients. The overall findings will contribute to guide the choice of proper assessment tool and the development of effective rehabilitation programs.

NCT ID: NCT01912794 Unknown status - Stroke Clinical Trials

Postural Responses to External Perturbation in Post-Stroke

Start date: August 2013
Phase: N/A
Study type: Interventional

To maintain stable body balance in daily activities, the ability to respond to external perturbations is an essential factor. Such capacity is limited in pathological conditions, such as in stroke, in which postural control is impaired due to lesions to the central nervous system. Impairment to postural control increases body sway during upright posture and leads to augmented frequency of falls. In this sense, the identification of mechanisms involved in body balance disorders after stroke is particularly important in situations of postural perturbation. The purpose of this project is to evaluate reactive postural responses to unpredictable external perturbations, analyzing postural dysfunctions caused by lesion to different brain areas as a result of stroke, and test principles of dynamic body balance rehabilitation.

NCT ID: NCT01910454 Completed - Stroke Clinical Trials

Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke

COSTAR
Start date: August 2013
Phase: Phase 1
Study type: Interventional

Stroke is the most serious disabling condition in the United States and the developed world. Novel stroke rehabilitation approaches, such as task-specific training, have shown promise in improving an individual's recovery in the rehabilitation setting; however, evidence suggests that these improvements are not generalized or transferred to the home, community, or work settings. Thus, these interventions usually do not impact overall health and participation outcomes. This research study seeks to improve task-specific training as a stroke rehabilitation approach by integrating it with evidence-based cognitive-oriented strategies which have shown great promise as a way to address the limitations of task-specific training. The new treatment protocol is called Cognitive-Oriented Strategy Training Augmented Rehabilitation, or COSTAR. The hypothesis of this study is that COSTAR will result in more efficient functional skill acquisition, better long-term retention of skills learned, and generalization and transfer of skills learned to home, community, and work settings.

NCT ID: NCT01910363 Unknown status - Clinical trials for Lower Limb Spasticity After Stroke

Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke

A2NTX
Start date: July 2013
Phase: Phase 2/Phase 3
Study type: Interventional

To test the safety and efficacy of a new generation botulinum toxin preparation A2NTX for treating stroke patients with lower limb spasticity. - we study the degree of spasticity in the ankle and knee joints, and walking speed in 30 patients with stroke before and after injecting 300 units of BOTOX or A2NTX in a blinded manner as for the patient, the physician, and the examiner. - we also assess the safety of A2NTX and compare it to that of BOTOX.